Success Story: Without RFE, An India-Based Assistant Research Professor of Medicine Achieves NIW Success
Client’s Testimonial:
“I truly appreciate your hard work and the team's focus on detail. Your dedication gives me confidence in a positive outcome in my case. Thank you.”
On March 20th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Research Professor of Medicine in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Assistant Research Professor of Medicine
Country of Origin: India
State of Residence at the Time of Filing: Indiana
Approval Notice Date: March 20th, 2025
Processing Time: 8 months, 24 days (Premium Processing Upgrade Requested)
Case Summary:
We are proud to share the success story of a Ph.D. holder in environmental toxicology, whose I-140 NIW (National Interest Waiver) petition was approved in 8 months and 24 days following an upgrade to premium processing. This case illustrates how a carefully crafted petition can clearly demonstrate the national importance of a client’s proposed work and support a favorable outcome.
Our client is currently employed as an assistant research professor and specializes in molecular biology, with a focus on investigating the molecular mechanisms of immuno-cardiotoxicity and its role in adverse cardiac remodeling following myocardial infarction. His research seeks to develop improved treatment strategies and health management approaches to better care for post-heart attack patients and reduce mortality rates associated with these conditions.
The petition, filed under the EB-2 NIW category, highlighted:
● 11 peer-reviewed journal articles,
● 2 conference abstracts,
● A citation record of 246 citations,
● At least 23 completed peer reviews for respected journals in his field.
We demonstrated that his research directly addresses urgent national healthcare challenges, including cardiovascular disease, the leading cause of death in the U.S., and a significant driver of healthcare costs. His work is supported by competitive funding from the National Institutes of Health (NIH), the Flight Attendant Medical Research Institute (FAMRI), and the Indian Council of Medical Research. These endorsements underscore the scientific merit and broader relevance of his work.To further support the petition, two letters of recommendation from leading experts in cardiovascular medicine and molecular biology were submitted. These letters recognized the originality and translational potential of his findings.
“[Client’s] outstanding contributions to the field of molecular biology render him a highly sought-after and influential researcher in the U.S.”
We are honored to have supported this promising researcher in his immigration journey and look forward to the continued impact of his work in advancing treatments for heart disease and strengthening national health outcomes.

